Brown Scientists Find New Way to Fight Brain Cancer

Scientists just cracked a major puzzle in the fight against glioblastoma, offering real hope to thousands of patients battling one of the most aggressive brain cancers.

Researchers at Brown University Health identified a tiny molecule called miR-181d that controls how brain tumor cells respond to treatment. The discovery could transform how doctors treat this devastating disease, which has long frustrated medical teams because different cells within the same tumor behave completely differently.

Dr. Clark Chen, who leads Brown's Brain Tumor Program, explained that his team took a radical new approach. Instead of studying how an entire tumor responds to treatment on average, they focused on why individual cells within the same tumor act so differently.

What they found changes everything. The molecule miR-181d controls how much repair protein each cell produces. Cells with more of this protein basically armor themselves against chemotherapy and keep growing while their neighbors die off.

Here's where it gets exciting: the researchers discovered they can inject miR-181d molecules directly into tumors to even out these protein levels. This makes chemotherapy work better across all the cancer cells, not just some of them.

The Ripple Effect

This breakthrough reaches far beyond Brown's labs in Providence. Researchers at Stanford University, Johns Hopkins University, and the University of Minnesota are already working together to develop new therapies based on this discovery.

Dr. Gatikrushna Singh from the University of Minnesota called it "an exciting step forward" that opens the door to gene therapy strategies that could be "truly game changing" for glioblastoma patients. Teams are now developing treatments that could level miR-181d in tumors, helping thousands of patients respond better to chemotherapy.

The research also solves a scientific mystery that has puzzled cancer researchers for years: why tumors maintain so much internal variability. Understanding this fundamental behavior could unlock new treatment approaches for other cancers too.

For the roughly 13,000 Americans diagnosed with glioblastoma each year, this discovery represents something many thought impossible just a few years ago: a real path forward in treating a cancer that has resisted nearly every attempt to stop it.

The collaboration between multiple research institutions shows how sharing knowledge accelerates progress, turning laboratory discoveries into treatments that could save lives within years, not decades.